Skip to main content
Top
Published in: Indian Journal of Gastroenterology 1/2014

01-01-2014 | Original Article

Primary extrahepatic portal vein obstruction in adults: A single center experience

Authors: Pooja Amarapurkar, Nirav Bhatt, Nikhil Patel, Deepak Amarapurkar

Published in: Indian Journal of Gastroenterology | Issue 1/2014

Login to get access

Abstract

Background

Extrahepatic portal venous obstruction (EHPVO) is a heterogenous disease with regards to etiology, pathogenesis, age, and geographical location. This study analyzed our experience with EHPVO in adults aged >20 years. EHPVO associated with pancreatitis and abdominal lymph node tuberculosis compressing the portal vein was excluded.

Methods

Retrospective analysis of the hospital database from January 2000 to December 2009 was done. All patients with liver disease who are attending our department were also prospectively evaluated with Doppler ultrasound for the portal venous system to study the prevalence of EHPVO. Clinical, biochemical, and imaging findings; work up for thrombophilia; treatment given; and follow up were evaluated.

Result

In the retrospective analysis, primary EHPVO in adults was seen in 108/10,095 (1 %), and in the prospective analysis, it was seen in 16/2,188 (0.73 %). The main clinical presentations were abdominal pain and variceal bleed. Imaging findings included portal cavernoma, portal biliopathy, gallbladder calculi, collaterals, and ascites. The major causative factors identified were hyperhomocysteinemia, antiphospholipid antibodies, and myeloproliferative disorders, while, in a third of patients, none of these risk factors could be identified. Twelve patients were subjected to surgery, while the remaining patients were managed either by medical, endoscopic, or interventional radiological techniques. More than 2 years of follow up was available in 90 patients; two patients died due to uncontrolled bleeding, seven patients required surgery, seven patients showed deterioration in liver function, and one patient developed hepatocellular carcinoma. In the prospective study, three patients were subjected to surgery, and the others were managed medically.

Conclusion

Primary EHPVO is an uncommon cause of portal hypertension in adults in India, and its etiological spectrum is comparable to the West.
Literature
1.
go back to reference Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol. 2000;32:865–71.PubMedCrossRef Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol. 2000;32:865–71.PubMedCrossRef
2.
go back to reference Sarin SK, Sollano JD, Chawla YK, et al. Consensus on extra-hepatic portal vein obstruction. Liver Int. 2006;26:512–9.PubMedCrossRef Sarin SK, Sollano JD, Chawla YK, et al. Consensus on extra-hepatic portal vein obstruction. Liver Int. 2006;26:512–9.PubMedCrossRef
3.
go back to reference Garcia Pagan JC, Hernandez GM. Extrahepatic portal vein thrombosis. Semin Liver Dis. 2008;3:282–92.CrossRef Garcia Pagan JC, Hernandez GM. Extrahepatic portal vein thrombosis. Semin Liver Dis. 2008;3:282–92.CrossRef
5.
go back to reference Franchis R', Baveno V, Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53:762–8.PubMedCrossRef Franchis R', Baveno V, Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53:762–8.PubMedCrossRef
6.
go back to reference Plessier A, Darwish-Murad S, Hernandez-Guerra M, et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology. 2010;51:210–8.PubMedCrossRef Plessier A, Darwish-Murad S, Hernandez-Guerra M, et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology. 2010;51:210–8.PubMedCrossRef
7.
go back to reference Sarin SK, Agarwal SR. Extrahepatic portal vein obstruction. Semin Liver Dis. 2002;1:43–58.CrossRef Sarin SK, Agarwal SR. Extrahepatic portal vein obstruction. Semin Liver Dis. 2002;1:43–58.CrossRef
8.
go back to reference Yachha SK. Portal hypertension in children: an Indian perspective. J Gastroenterol Hepatol. 2002;17:S228–31.PubMedCrossRef Yachha SK. Portal hypertension in children: an Indian perspective. J Gastroenterol Hepatol. 2002;17:S228–31.PubMedCrossRef
9.
go back to reference Arora NK, Lodha R, Gulati S, et al. Portal hypertension in north Indian children. Indian J Pediatr. 1998;65:85–91.CrossRef Arora NK, Lodha R, Gulati S, et al. Portal hypertension in north Indian children. Indian J Pediatr. 1998;65:85–91.CrossRef
10.
go back to reference Simon EG, Joseph AJ, George B, et al. Aetiology of pediatric portal hypertension-experience of a tertiary care centre in South India. Trop Dr. 2009;39:42–4.CrossRef Simon EG, Joseph AJ, George B, et al. Aetiology of pediatric portal hypertension-experience of a tertiary care centre in South India. Trop Dr. 2009;39:42–4.CrossRef
11.
go back to reference Poddar U, Thapa BR, Rao KLN, Singh K. Etiological spectrum of esophageal varices due to portal hypertension in Indian children: is it different from the West? J Gastroenterol Hepatol. 2008;23:1354–7.PubMedCrossRef Poddar U, Thapa BR, Rao KLN, Singh K. Etiological spectrum of esophageal varices due to portal hypertension in Indian children: is it different from the West? J Gastroenterol Hepatol. 2008;23:1354–7.PubMedCrossRef
12.
go back to reference Zargar SA, Javid G, Khan BA, et al. Endoscopic ligation compared with sclerotherapy for bleeding esophageal varices in children with extrahepatic portal venous obstruction. Hepatology. 2002;36:666–72.PubMedCrossRef Zargar SA, Javid G, Khan BA, et al. Endoscopic ligation compared with sclerotherapy for bleeding esophageal varices in children with extrahepatic portal venous obstruction. Hepatology. 2002;36:666–72.PubMedCrossRef
13.
go back to reference Rajani R, Bjornsson E, Bergquist A, et al. The epidemiology and clinical features of portal vein thrombosis: multicentre study. Aliment Pharmacol Ther. 2010;32:1154–6.PubMedCrossRef Rajani R, Bjornsson E, Bergquist A, et al. The epidemiology and clinical features of portal vein thrombosis: multicentre study. Aliment Pharmacol Ther. 2010;32:1154–6.PubMedCrossRef
14.
go back to reference Sarin SK. Non-cirrhotic portal hypertension. In: Advances in Therapeutic Hepatology: A World View. Chicago: IASL; 1998. p. 111–24. Postgraduate course. Sarin SK. Non-cirrhotic portal hypertension. In: Advances in Therapeutic Hepatology: A World View. Chicago: IASL; 1998. p. 111–24. Postgraduate course.
15.
go back to reference Kiladjian JJ, Cervantes F, Leebeek FW, et al. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood. 2008;111:4922–9. Kiladjian JJ, Cervantes F, Leebeek FW, et al. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood. 2008;111:4922–9.
16.
go back to reference Qi X, Yang Z, Bai M, Shi X, Han G, Fan D. Meta-analysis: the significance of screening for JAK2V617F mutation in Budd–Chiari syndrome and portal venous system thrombosis. Aliment Pharmacol Ther. 2011;33:1087–103.PubMedCrossRef Qi X, Yang Z, Bai M, Shi X, Han G, Fan D. Meta-analysis: the significance of screening for JAK2V617F mutation in Budd–Chiari syndrome and portal venous system thrombosis. Aliment Pharmacol Ther. 2011;33:1087–103.PubMedCrossRef
17.
go back to reference Hoekstra J, Bresser EL, Smallberg JH, Spaander MC, Leebeek FW, Janssen HL. Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms. J Thromb Haemost. 2011;9:2208–14.PubMedCrossRef Hoekstra J, Bresser EL, Smallberg JH, Spaander MC, Leebeek FW, Janssen HL. Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms. J Thromb Haemost. 2011;9:2208–14.PubMedCrossRef
18.
go back to reference Amarapurkar DN, Patel ND, Jatania J. Primary mesenteric venous thrombosis: a study from western India. Indian J Gastroenterol. 2007;26:113–7.PubMed Amarapurkar DN, Patel ND, Jatania J. Primary mesenteric venous thrombosis: a study from western India. Indian J Gastroenterol. 2007;26:113–7.PubMed
19.
go back to reference Qi X, Han G, Yin Z, et al. Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients. Dig Dis Sci. 2012;57:1072–82.PubMedCrossRef Qi X, Han G, Yin Z, et al. Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients. Dig Dis Sci. 2012;57:1072–82.PubMedCrossRef
20.
go back to reference Condat B, Pessione F, Hillarie S, et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology. 2001;120:490–7.PubMedCrossRef Condat B, Pessione F, Hillarie S, et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology. 2001;120:490–7.PubMedCrossRef
21.
go back to reference Plessier A, Rautou PE, Valla DC. Management of hepatic vascular diseases. J Hepatol. 2012;56 Suppl 1:S25–38.PubMedCrossRef Plessier A, Rautou PE, Valla DC. Management of hepatic vascular diseases. J Hepatol. 2012;56 Suppl 1:S25–38.PubMedCrossRef
22.
go back to reference Denninger MH, Chait Y, Casadevall N, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatolology. 2000;31:587–91.CrossRef Denninger MH, Chait Y, Casadevall N, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatolology. 2000;31:587–91.CrossRef
23.
go back to reference Primignani M, Martinelli I, Bucciarelli P, et al. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatolology. 2005;41:603–8.CrossRef Primignani M, Martinelli I, Bucciarelli P, et al. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatolology. 2005;41:603–8.CrossRef
24.
go back to reference Amitrano L, Guardascione MA, Scaglione M, et al. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol. 2007;102:2464–70.PubMedCrossRef Amitrano L, Guardascione MA, Scaglione M, et al. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol. 2007;102:2464–70.PubMedCrossRef
25.
go back to reference Amarapurkar D, Punamiya S, Patel N, Parekh S, Mehta S, Shah N. Prevalence of JAK2V617F mutation in intra-abdominal venous thrombosis. Trop Gastroenterol. 2011;32:279–84. Amarapurkar D, Punamiya S, Patel N, Parekh S, Mehta S, Shah N. Prevalence of JAK2V617F mutation in intra-abdominal venous thrombosis. Trop Gastroenterol. 2011;32:279–84.
Metadata
Title
Primary extrahepatic portal vein obstruction in adults: A single center experience
Authors
Pooja Amarapurkar
Nirav Bhatt
Nikhil Patel
Deepak Amarapurkar
Publication date
01-01-2014
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 1/2014
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-013-0368-4

Other articles of this Issue 1/2014

Indian Journal of Gastroenterology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine